An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2875
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies ; volume:11 ; number:1 ; day:15 ; month:10 ; year:2012 ; pages:1 ; date:10.2012
Malaria journal ; 11, Heft 1 (15.10.2012), 1, 10.2012
- Urheber
-
Staehli Hodel, Eva Maria
- Beteiligte Personen und Organisationen
-
Kay, Katherine
Hayes, Daniel
Terlouw, Anja
Hastings, Ian
SpringerLink (Online service)
- DOI
-
10.1186/1475-2875-11-S1-P91
- URN
-
urn:nbn:de:1111-2016080638014
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Staehli Hodel, Eva Maria
- Kay, Katherine
- Hayes, Daniel
- Terlouw, Anja
- Hastings, Ian
- SpringerLink (Online service)
Ähnliche Objekte (12)
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria
Adherence to prescribed artemisinin-based combination therapy in Garissa and Bunyala districts, Kenya
From chloroquine to artemisinin-based combination therapy: the Sudanese experience
Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
Pharmacokinetics/pharmacodynamics of chloroquine and artemisinin-based combination therapy with primaquine
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia
Adaptive dosing of anticancer drugs in neonates: facilitating evidence-based dosing regimens
Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts
Novel artemisinin-based antiviral, antimalarial and anticancer hybrid compounds via click chemistry
Stabilizing supply of artemisinin and artemisinin-based combination therapy in an era of wide-spread scale-up
Willingness and ability to pay for artemisinin-based combination therapy in rural Tanzania
Preference for Artemisinin–based combination therapy among healthcare providers, Lokoja, North-Central Nigeria